[국제]”Supply 13.5 million doses of vaccine every week”…Quickly reviewed Johnson & Johnson vaccine

[국제]”Supply 13.5 million doses of vaccine every week”…Quickly reviewed Johnson & Johnson vaccine

by

[앵커]

As countries around the world are working hard to expand the distribution of vaccines, the United States has decided to significantly increase its supply.

The European Medicines Agency has decided to expedite the application of Johnson & Johnson vaccines for use.

Reporter Kim Jin-ho.

[기자]

The U.S. government is active to expand the supply of the COVID-19 vaccine.

President Biden has pledged to supply 100 million doses of vaccine within 100 days of taking office, and he is encouraging vaccine companies to protect it.

The White House announced that it will supply 1.5 million doses of vaccine each week on the 16th local time.

[젠 사키 / 백악관 대변인 : 백신 공급을 매주 천3백50만 회분으로 늘릴 것입니다. 바이든 대통령 취임 당시 공급된 양보다 57% 늘어났습니다.]

The White House also says it is sending 2 million doses this week by doubling its vaccines to pharmacies.

In Europe, we plan to increase the supply of vaccines by expediting applications for marketing approval of new vaccines.

The European Medicines Agency and EMA announced on the 16th local time that the US pharmaceutical company Johnson & Johnson has applied for conditional marketing approval for the Corona 19 vaccine.

EMA said it would rush the evaluation of the vaccine ahead of the usual schedule, and explained that a conclusion on approval could be announced as early as mid-next month.

EMA explained that some of the data on Johnson & Johnson vaccines have already been reviewed as part of the phased review process, allowing quick conclusions on approval or not.

When the EMA makes a recommendation for marketing approval for the vaccine, the EU Commission makes a final decision.

When Johnson & Johnson’s COVID-19 vaccine is approved, it will be the fourth approved COVID-19 vaccine in the EU.

Earlier, the EU Commission approved the conditional sale of the COVID-19 vaccine developed by the US pharmaceutical company Pfizer-German Bioentech, the US Modena, and the multinational pharmaceutical company AstraZeneca, respectively, in accordance with EMA’s recommendations.

This is YTN Kim Jin-ho.

[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]

.Source